Terms: = Breast cancer AND RUNX1T1, ENSG00000079102, 862 AND Prognosis
28 results:
1. [Clinical characteristics and prognostic factors of breast cancer patients with tumor deposits in the ipsilateral axillary region].
Xiao JJ; Huang ML; Yan CJ; Ling R; Wei HL
Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):146-154. PubMed ID: 38418189
[No Abstract] [Full Text] [Related]
2. Prognostic and clinicopathological significance of CD155 expression in cancer patients: a meta-analysis.
Zhang D; Liu J; Zheng M; Meng C; Liao J
World J Surg Oncol; 2022 Oct; 20(1):351. PubMed ID: 36309698
[TBL] [Abstract] [Full Text] [Related]
3. Clinical characteristics and prognostic nomogram for patients with insular thyroid carcinoma: a population-based analysis.
Yin L; Hou S; Hou LL; Pu CC
Endocrine; 2023 Feb; 79(2):331-341. PubMed ID: 36207552
[TBL] [Abstract] [Full Text] [Related]
4. Association of Long-term Oncologic prognosis With Minimal Access breast Surgery vs Conventional breast Surgery.
Wan A; Liang Y; Chen L; Wang S; Shi Q; Yan W; Cao X; Zhong L; Fan L; Tang P; Zhang G; Xiong S; Wang C; Zeng Z; Wu X; Jiang J; Qi X; Zhang Y
JAMA Surg; 2022 Dec; 157(12):e224711. PubMed ID: 36197680
[TBL] [Abstract] [Full Text] [Related]
5. Predictive value of neutrophil-to-lymphocyte-ratio in neoadjuvant-treated patients with breast cancer.
von Au A; Shencoru S; Uhlmann L; Mayer L; Michel L; Wallwiener M; Hennigs A; Deutsch T; Riedel F; Heil J; Golatta M; Schneeweiss A; Schütz F; Domschke C
Arch Gynecol Obstet; 2023 Apr; 307(4):1105-1113. PubMed ID: 35980458
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathological Features and Survival for Low ER-positive breast-cancer Patients.
He A; Zhou T
Altern Ther Health Med; 2022 Sep; 28(6):36-41. PubMed ID: 35648695
[TBL] [Abstract] [Full Text] [Related]
7. Development and validation of a nomogram to predict survival for advanced male breast cancer.
Zhang LP; Lin H; Wang AJ
Andrologia; 2022 Sep; 54(8):e14479. PubMed ID: 35618959
[TBL] [Abstract] [Full Text] [Related]
8. prognosis by cancer type and incidence of zoledronic acid-related osteonecrosis of the jaw: a single-center retrospective study.
Hata H; Imamachi K; Ueda M; Matsuzaka M; Hiraga H; Osanai T; Harabayashi T; Fujimoto K; Oizumi S; Takahashi M; Yoshikawa K; Sato J; Yamazaki Y; Kitagawa Y
Support Care Cancer; 2022 May; 30(5):4505-4514. PubMed ID: 35113225
[TBL] [Abstract] [Full Text] [Related]
9. Characteristics of metastasis and survival between male and female breast cancer with different molecular subtypes: A population-based observational study.
Fang W; Huang Y; Han X; Peng J; Zheng M
Cancer Med; 2022 Feb; 11(3):764-777. PubMed ID: 34898007
[TBL] [Abstract] [Full Text] [Related]
10. runx1t1, a potential prognostic marker in breast cancer, is co-ordinately expressed with ERα, and regulated by estrogen receptor signalling in breast cancer cells.
Saikia S; Pal U; Kalita DJ; Rai AK; Sarma A; Kataki AC; Limaye AM
Mol Biol Rep; 2021 Jul; 48(7):5399-5409. PubMed ID: 34264479
[TBL] [Abstract] [Full Text] [Related]
11. Retrospective analysis of sentinel lymph node biopsy using methylene blue dye for early breast cancer.
Yang S; Xiang HY; Xin L; Zhang H; Zhang S; Cheng YJ; Liu Q; Xu L; Li T; Duan XN; Ye JM; Liu YH
Chin Med J (Engl); 2021 Jan; 134(3):318-325. PubMed ID: 33522727
[TBL] [Abstract] [Full Text] [Related]
12. Differences in Genomic Alterations Between Brain Metastases and Primary Tumors.
Dono A; Takayasu T; Yan Y; Bundrant BE; Arevalo O; Lopez-Garcia CA; Esquenazi Y; Ballester LY
Neurosurgery; 2021 Feb; 88(3):592-602. PubMed ID: 33369669
[TBL] [Abstract] [Full Text] [Related]
13. Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis.
Gao ZH; Li CX; Liu M; Jiang JY
BMC Cancer; 2020 Nov; 20(1):1150. PubMed ID: 33238978
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic value of the Residual cancer Burden index according to breast cancer subtype: Validation on a cohort of BC patients treated by neoadjuvant chemotherapy.
Hamy AS; Darrigues L; Laas E; De Croze D; Topciu L; Lam GT; Evrevin C; Rozette S; Laot L; Lerebours F; Pierga JY; Osdoit M; Faron M; Feron JG; Laé M; Reyal F
PLoS One; 2020; 15(6):e0234191. PubMed ID: 32579551
[TBL] [Abstract] [Full Text] [Related]
15. A preliminary report of head-to-head comparison of 18-gene-based clinical-genomic model and oncotype DX 21-gene assay for predicting recurrence of early-stage breast cancer.
Yang PS; Lee YH; Chung CF; Chang YC; Wang MY; Lo C; Tsai LW; Shih KH; Lei J; Yu BL; Cheng SH; Huang CS
Jpn J Clin Oncol; 2019 Dec; 49(11):1029-1036. PubMed ID: 31287883
[TBL] [Abstract] [Full Text] [Related]
16. Development and Application of a Machine Learning Approach to Assess Short-term Mortality Risk Among Patients With cancer Starting Chemotherapy.
Elfiky AA; Pany MJ; Parikh RB; Obermeyer Z
JAMA Netw Open; 2018 Jul; 1(3):e180926. PubMed ID: 30646043
[TBL] [Abstract] [Full Text] [Related]
17. SYCP2 expression is a novel prognostic biomarker in luminal A/B breast cancer.
Wu C; Tuo Y
Future Oncol; 2019 Mar; 15(8):817-826. PubMed ID: 30511892
[TBL] [Abstract] [Full Text] [Related]
18. Risk Assessment after Neoadjuvant Chemotherapy in Luminal breast cancer Using a Clinicomolecular Predictor.
Loibl S; Weber K; Huober J; Krappmann K; Marmé F; Schem C; Engels K; Pfitzner BM; Kümmel S; Furlanetto J; Hartmann A; Darb-Esfahani S; Müller V; Staebler A; von Minckwitz G; Kronenwett R; Denkert C
Clin Cancer Res; 2018 Jul; 24(14):3358-3365. PubMed ID: 29618617
[No Abstract] [Full Text] [Related]
19. [The comparison of characters between invasive micropapillary carcinoma and invasive ductal carcinoma not otherwise specified of the breast].
Hua B; Lu X; Xiao WZ; He SR; Wang Z
Zhonghua Wai Ke Za Zhi; 2017 Oct; 55(10):770-774. PubMed ID: 29050179
[No Abstract] [Full Text] [Related]
20. Survival after breast cancer local recurrence according to therapeutic strategies.
Houvenaeghel G; Boher JM; Michel V; Bannier M; Minsat M; Tallet A; Cohen M; Buttarelli M; Resbeut M; Lambaudie E
Eur J Surg Oncol; 2017 Aug; 43(8):1409-1414. PubMed ID: 28536053
[TBL] [Abstract] [Full Text] [Related]
[Next]
